| Entry |
|
|---|
| Name |
Methylphenidate (USAN/INN);
Daytrana (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C14H19NO2
|
|---|
| Exact mass |
233.1416
|
|---|
| Mol weight |
233.31
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
| Product (DG00969): | D04999<US> D01296<JP/US> |
|
|---|
| Efficacy |
Stimulant (central) |
|---|
| Disease |
Attention deficit hyperactivity disorder [DS: H01895] |
|---|
| Comment |
piperidine derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
N06BA Centrally acting sympathomimetics
N06BA04 Methylphenidate
D04999 Methylphenidate (USAN/INN) <US>
USP drug classification [BR:br08302]
Central Nervous System Agents
Attention Deficit Hyperactivity Disorder Agents, Non-amphetamines
Methylphenidate
D04999 Methylphenidate (USAN/INN)
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D04999 Methylphenidate (USAN/INN) <US>
SLC6A3 (DAT1)
D04999 Methylphenidate (USAN/INN) <US>
Narcotics and psychotropics in Japan [br08308.html]
Psychotropics by Control Act Article 2 Table 31 (10 substances)
D04999
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 C1c C 24.3131 -18.3693
2 C8y C 24.3014 -19.7673
3 C1y C 23.1133 -17.6530
4 C7a C 25.5364 -17.6763
5 C8x C 23.0840 -20.4546
6 C8x C 25.5072 -20.4779
7 C1x C 21.8959 -18.3403
8 N1x N 23.1307 -16.2550
9 O7a O 25.5538 -16.2783
10 O6a O 26.7421 -18.3926
11 C8x C 23.0724 -21.8583
12 C8x C 25.4898 -21.8759
13 C1x C 20.6902 -17.6296
14 C1x C 21.9249 -15.5385
15 C1a C 26.7712 -15.5910
16 C8x C 24.2665 -22.5689
17 C1x C 20.7018 -16.2258
BOND 18
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 1
9 4 10 2
10 5 11 1
11 6 12 2
12 7 13 1
13 8 14 1
14 9 15 1
15 11 16 2
16 13 17 1
17 12 16 1
18 14 17 1
|
|---|
